Fifth patient treated with CER-1236 underwent stem cell transplant following lack of response to prior therapies; Company initiates third planned ...

Vafseo® demonstrated a clinically meaningful safety outcome benefit in U.S. patients with anemia due to CKD on dialysis utilizing TIW dosing ...

Detailed price information for Akebia Therapeutics (AKBA-Q) from The Globe and Mail including charting and trades.

Celldetective is an open-source software integrating segmentation, tracking, and event detection to perform high-throughput end-to-end study of dynamic cell interactions, without requiring coding ...

The drug and biotech sector is in a recovery mode, after going through a difficult period between 2022 and 2024, backed by ...

Fifth patient treated with CER-1236 underwent stem cell transplant following lack of response to prior therapies; Company initiates third planned cohort in ongoing Phase 1 study in hematologic ...

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...

People who brought their blood sugar back to normal after a prediabetes diagnosis cut their risk of cardiovascular death or ...

Nothing unveiled Phone (4b), the first smartphone in the (b) series and a new entry point to the Nothing product ecosystem.

Nashville welcomed SHM Converge 2026, and with it one of the conference’s most anticipated annual traditions: the Updates in Hospital Medicine session. Kencee Graves, MD, FHM, clinical professor of ...

THE American Thoracic Society (ATS) International Conference 2026, held in Orlando, Florida, USA, May 15–20, united the pulmonary medicine community for a week of discussion on the latest data, ...